Nicotine and Cardiovascular Health: When Poison is Addictive – a WHF Policy Brief

To prevent first and recurrent cardiovascular events in people living with cardiovascular risk factors or disease.

To prevent nicotine addiction and increased risks of health harms.

To prevent and reduce nicotine addiction.

To reduce the number of young patients with cardiovascular diseases.

To reduce the number of pregnant smokers.

To reduce second-hand exposure to tobacco smoke and ENDS aerosols.

To increase community and political support for regulatory measures.

To free patients from nicotine addiction and reduce their risks of tobacco-related diseases and their clinical complications.

To reduce the tobacco-related socio-economic burden of disease.

To protect and promote the highest standards of health for all people of all ages.

To ensure that tobacco regulatory policies are not weakened or influenced by the tobacco industry.

To close the knowledge gap on the long-term effects of newer tobacco and recreational nicotine products on cardiovascular health.

To better understand how to apply tobacco control measures more effectively in order to curb the burden of tobacco uptake and use among more vulnerable populations.

To prevent tobacco industry interference and promotion of tobacco industry interests.

To address conflicts of interest and biased studies.

To ensure scientific integrity.

To improve people’s health by eliminating or reducing their use of tobacco and recreational nicotine products by implementing measures that prevent initiation, promote and support cessation, and discourage consumption of such products.

To prevent and reduce health harms and injuries from use of harmful products.

To reduce nicotine concentration and delivery and thereby limit the addiction potential of tobacco and nicotine products and their related adverse health effects.

To implement and reinforce Articles 9 and 14 of the WHO FCTC.

To increase the prices and reduce the affordability of tobacco and non-medical nicotine products, and thereby discourage and reduce their consumption, especially by youths.

To raise additional income for governments and the promotion of health.

To implement and reinforce Article 6 of the WHO FCTC.

To reduce the appeal of tobacco and nicotine products, especially among youth.

To reduce exposure to marketing strategies through packaging.

To warn consumers about the dangers of tobacco and nicotine.

To implement and reinforce Articles 11, 12, and 13 of the WHO FCTC.

To reduce the appeal of tobacco and nicotine products, especially among youth.

To prevent the consumption of substances that may be harmful and unsafe for inhalation.

To simplify the regulation of e-cigarette solutions.

To implement and reinforce Article 9 of the WHO FCTC.

To protect the public from exposure to second-hand tobacco and nicotine aerosols.

To implement and reinforce Article 8 of the WHO FCTC.

To reduce exposure to marketing strategies that encourage tobacco and recreational nicotine product consumption, including at points of sale and on the internet.

To implement and reinforce Articles 5.3 and 13 of the WHO FCTC.

To prevent misleading claims that may encourage the consumption of potentially harmful products.

To prevent misleading claims on the addictive nature of nicotine and on the effectiveness of newer products as tobacco cessation tools.

To implement and reinforce Articles 5.3, 11 and 13 of the WHO FCTC.

To limit and reduce the availability of tobacco and nicotine products, especially to young people.

To reduce exposure to marketing strategies at point of sale.